MYB and myeloid leukemia: Knockdown of MYB in myeloid leukemia cells induced pro-apoptotic Bcl-2 related ovarian killer (BOK) and Bcl-2 interacting mediator of cell death (BIM) and led to sensitization to panobinostat, which is another clinically approved HDAC inhibitor.